Antares Pharma PE Ratio 2006-2019 | ATRS

Current and historical p/e ratio for Antares Pharma (ATRS) from 2006 to 2019. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. Antares Pharma PE ratio as of February 14, 2020 is 357.00.
Antares Pharma PE Ratio Historical Data
Date Stock Price TTM Net EPS PE Ratio
2020-02-14 3.57 357.00
2019-09-30 3.35 $0.01 334.50
2019-06-30 3.29 $-0.01 0.00
2019-03-31 3.03 $-0.03 0.00
2018-12-31 2.72 $-0.04 0.00
2018-09-30 3.36 $-0.10 0.00
2018-06-30 2.58 $-0.12 0.00
2018-03-31 2.20 $-0.11 0.00
2017-12-31 1.99 $-0.10 0.00
2017-09-30 3.24 $-0.11 0.00
2017-06-30 3.22 $-0.12 0.00
2017-03-31 2.84 $-0.14 0.00
2016-12-31 2.33 $-0.16 0.00
2016-09-30 1.68 $-0.17 0.00
2016-06-30 1.05 $-0.17 0.00
2016-03-31 0.87 $-0.14 0.00
2015-12-31 1.21 $-0.14 0.00
2015-09-30 1.69 $-0.18 0.00
2015-06-30 2.08 $-0.19 0.00
2015-03-31 2.71 $-0.25 0.00
2014-12-31 2.57 $-0.27 0.00
2014-09-30 1.83 $-0.23 0.00
2014-06-30 2.67 $-0.23 0.00
2014-03-31 3.50 $-0.20 0.00
2013-12-31 4.47 $-0.16 0.00
2013-09-30 4.06 $-0.16 0.00
2013-06-30 4.16 $-0.14 0.00
2013-03-31 3.58 $-0.13 0.00
2012-12-31 3.81 $-0.10 0.00
2012-09-30 4.36 $-0.06 0.00
2012-06-30 3.63 $-0.04 0.00
2012-03-31 3.23 $-0.03 0.00
2011-12-31 2.20 $-0.05 0.00
2011-09-30 2.32 $-0.07 0.00
2011-06-30 2.21 $-0.08 0.00
2011-03-31 1.80 $-0.08 0.00
2010-12-31 1.70 $-0.08 0.00
2010-09-30 1.45 $-0.09 0.00
2010-06-30 1.76 $-0.11 0.00
2010-03-31 1.37 $-0.12 0.00
2009-12-31 1.14 $-0.14 0.00
2009-09-30 1.11 $-0.15 0.00
2009-06-30 0.89 $-0.16 0.00
2009-03-31 0.43 $-0.18 0.00
2008-12-31 0.37 $-0.19 0.00
2008-09-30 0.73 $-0.20 0.00
2008-06-30 0.72 $-0.19 0.00
2008-03-31 1.07 $-0.18 0.00
2007-12-31 0.98 $-0.14 0.00
2007-09-30 1.42 $-0.12 0.00
2007-06-30 1.58 $-0.12 0.00
2007-03-31 1.29 $-0.13 0.00
2006-12-31 1.20 $-0.17 0.00
Sector Industry Market Cap Revenue
Medical Medical & Dental Supplies $0.583B $0.064B
Antares Pharma, Inc. develops, commercializes and markets novel delivery solutions, including needle-free and mini-needle injector systems, gel technologies and transdermal products, which improve both the efficiency of drug therapies and the quality of life for patients. The Company currently distributes its needle-free injector systems for the delivery of insulin and growth hormone in over 20 countries and an estradiol transdermal patch for hormone replacement therapy.
Stock Name Country Market Cap PE Ratio
Becton Dickinson (BDX) United States $70.565B 22.38
McKesson (MCK) United States $29.730B 11.66
Align Technology (ALGN) United States $21.670B 55.43
AmerisourceBergen (ABC) United States $19.428B 13.03
Laboratory Of America Holdings (LH) United States $18.962B 17.27
Cardinal Health (CAH) United States $17.396B 10.86
Cooper (COO) United States $17.371B 28.61
Straumann Holding AG (SAUHF) Switzerland $15.709B 0.00
West Pharmaceutical Services (WST) United States $12.917B 53.88
DENTSPLY SIRONA (XRAY) United States $12.867B 25.15
Henry Schein (HSIC) United States $10.584B 19.71
CONMED (CNMD) United States $2.976B 39.57
Merit Medical Systems (MMSI) United States $2.259B 26.39
Patterson (PDCO) United States $2.203B 16.32
STAAR Surgical (STAA) United States $1.644B 85.84
Atrion (ATRI) United States $1.268B 34.94
Invacare (IVC) United States $0.302B 0.00
Lifevantage (LFVN) United States $0.226B 18.93
Pro-Dex (PDEX) United States $0.073B 20.14
Biolase (BIOL) United States $0.021B 0.00
Endologix (ELGX) United States $0.015B 0.00